Home / Stocks / Wockhardt Limited
WOCKPHARMA

Wockhardt Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹2,265.6

Change

-22.1 (-0.97%)

Open

₹2,290.0

Prev. Close

₹2,287.7

Day High

₹2,329.9

Day Low

₹2,243.0

Volume Analysis

Traded

689,934

Delivered

244,845

Delivery %

35.49%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (22.0%)

Weaknesses (2)

  • •Low return on equity (6.11%)
  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹2,402.9 ₹2,366.4 ₹2,316.0 ₹2,279.5 ₹2,229.1 ₹2,192.6 ₹2,142.2
Fibonacci ₹2,366.4 ₹2,333.2 ₹2,312.7 ₹2,279.5 ₹2,246.3 ₹2,225.8 ₹2,192.6
Camarilla ₹2,289.5 ₹2,281.53 ₹2,273.57 ₹2,279.5 ₹2,257.63 ₹2,249.67 ₹2,241.7

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+59.22%

1 Week

+3.58%

1 Month

+14.59%

3 Months

+16.7%

6 Months

+78.73%

1 Year

+69.52%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹299.45

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

7.89%

Net margin 11.62% × asset turnover 0.39x × equity multiplier 1.74x

Company Overview

Sector

Healthcare

Market Cap

₹36,814 Cr

P/E (TTM)

92.3

ROE

6.11%

Book Value

₹304.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 28 Sep 2026. Not investment advice.

TopFund Analysis

Wockhardt Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 52/100. The strongest factor is Financial Strength (91/100), while Valuation (3/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%); low return on equity (6.11%); promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

52/100 — Average

Data confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

91

Growth

21

Valuation

3

Cash Flow

38

Corporate Governance

43

Momentum

88

Institutional Ownership

62

Business Quality

60

Risk & Volatility

54

Liquidity

65

From Screener.in

  • −Stock is trading at 7.45 times its book value
  • −The company has delivered a poor sales growth of 4.49% over past five years.
  • −Company has a low return on equity of -1.43% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -9.31%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Trading window closed from 1 Oct 2026 until 48 hours after Q2 FY26 results.

Received 21 Aug 2026 customs order imposing ₹5 crore penalty and ₹10 crore redemption fine on Wockhardt for API misclassification.

Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations, 2015, we enclose herewith a copy of newspaper …

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 644 753 701 700 739 809 721 743 738 782 888 965 929
Expenses + 628 681 664 759 648 699 593 679 666 604 711 740 737
Operating Profit 16 72 37 -59 91 110 128 64 72 178 177 225 192
OPM % 2.5% 10.0% 5.0% -8.0% 12.0% 14.0% 18.0% 9.0% 10.0% 23.0% 20.0% 23.0% 21.0%
Other Income + 0 24 8 10 30 9 8 15 -77 21 15 67 31
Interest 79 76 77 73 73 73 60 48 48 55 60 50 52
Depreciation 55 55 55 58 54 55 55 53 56 53 65 53 55
Profit before tax -118 -35 -87 -180 -6 -9 21 -22 -109 91 67 189 116
Tax % 15.0% 109.0% -1.0% -2.0% 167.0% 78.0% 5.0% 105.0% -1.0% 10.0% 9.0% 13.0% 8.0%
Net Profit + -136 -73 -86 -177 -16 -16 20 -45 -108 82 61 164 107
EPS in Rs -9 -5 -6 -11 -1 -1 1 -2 -6 5 4 10 7
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 4,482 4,453 4,015 3,937 3,566 2,844 2,708 3,230 2,651 2,798 3,012 3,373 3,564
Expenses + 3,772 3,959 4,002 3,935 3,604 2,725 2,771 2,932 2,549 2,707 2,619 2,721 2,792
Operating Profit 709 494 13 2 -38 119 -63 298 102 91 393 652 772
OPM % 16.0% 11.0% 0.3% 0.1% -1.1% 4.2% -2.3% 9.0% 3.9% 3.2% 13.0% 19.0% 22.0%
Other Income + 67 66 114 -238 116 133 975 -163 -173 17 62 26 134
Interest 55 129 225 255 265 276 249 299 302 305 254 213 217
Depreciation 145 142 149 150 164 224 246 247 251 223 217 227 226
Profit before tax 575 289 -247 -641 -351 -247 417 -411 -624 -420 -16 238 463
Tax % 28.0% 13.0% -9.0% 4.0% -38.0% -82.0% -65.0% -32.0% 0.0% 12.0% 256.0% 16.0% —
Net Profit + 413 252 -226 -667 -217 -43 688 -279 -621 -472 -57 199 414
EPS in Rs 28 17 -14 -42 -14 -5 48 -17 -39 -30 -3 13 25
Dividend Payout % 54.0% 0.0% -56.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 3,362 3,720 3,281 2,797 2,619 2,616 3,321 3,777 3,282 3,282 4,272 4,859
Borrowings + 2,309 2,677 4,160 3,748 3,375 3,582 2,674 2,198 2,184 2,356 2,021 2,233
Other Liabilities + 1,213 1,622 1,486 1,528 1,764 1,894 1,696 2,168 2,113 1,899 1,726 1,405
Total Liabilities 6,939 8,074 8,982 8,128 7,813 8,148 7,746 8,215 7,651 7,614 8,100 8,578
Fixed Assets + 2,123 2,809 2,773 2,888 3,058 3,502 3,343 3,462 3,042 2,881 2,736 2,791
CWIP 1,007 1,036 1,244 1,433 1,445 1,585 1,379 1,342 1,539 1,722 2,033 2,379
Investments 341 0 563 214 0 0 0 0 0 0 422 412
Other Assets + 3,468 4,228 4,403 3,593 3,309 3,060 3,024 3,411 3,070 3,011 2,909 2,996
Total Assets 6,939 8,074 8,982 8,128 7,813 8,148 7,746 8,215 7,651 7,614 8,100 8,578
Equity Capital 55 55 55 55 55 55 55 72 72 77 81 81

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 355 -42 -269 68 183 649 -287 413 153 219 -22 390
Cash from Investing Activity + -222 -105 -684 635 93 -147 1,471 -204 -118 -138 -780 -231
Cash from Financing Activity + -76 193 1,254 -769 -776 -680 -1,171 -71 -315 334 409 -54
Net Cash Flow 57 46 301 -66 -500 -178 13 138 -280 415 -393 105
CFO/OP 73 -8 -1,887 4,697 -583 560 270 171 161 274 -13 63
Free Cash Flow -76 -105 -678 -238 127 486 -452 202 23 69 -377 76

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 55.14% → 49.09%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 41.62% 40.59% 38.06% 37.62% 36.21% 34.54% 33.5% 32.6% 32.79% 33.36% 32.84% 34.44%
Promoters 55.14% 54.93% 51.6% 51.99% 51.99% 49.09% 49.09% 49.09% 49.09% 49.09% 49.09% 49.09%
Government 0.0% 0.0% 0.01% 0.01% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.04% 0.02%
FII 3.03% 4.18% 5.49% 5.94% 6.7% 6.54% 6.82% 7.29% 7.1% 7.0% 7.09% 7.23%
DII 0.21% 0.3% 4.82% 4.45% 5.08% 9.82% 10.58% 11.0% 11.0% 10.55% 10.96% 9.24%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Wockhardt Limited (this stock) 36,814 92.3 7.45 6.11%
Emcure Pharmaceuticals L 37,595 36.5 7.59 20.1%
Narayana Hrudayalaya Ltd. 38,040 44.1 8.38 20.5%
Sai Life Sciences Limited 33,821 92.0 13.61 15.4%
Global Health Limited 40,516 70.8 10.24 15.2%
Krishna Inst Of Med Sci L 32,765 157.0 13.88 11.3%
Dr. Lal Path Labs Ltd. 32,299 57.4 12.83 22.3%

Which Mutual Funds Hold Wockhardt Limited?

Frequently Asked Questions about Wockhardt Limited

Community Sentiment

What are other investors saying about Wockhardt Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.